Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Qiagen NV    QGEN   NL0000240000

QIAGEN NV (QGEN)

Delayed Quote. Delayed  - 09/28 10:00:00 pm
27.3 USD   +0.66%
09/10 QIAGEN : Comments on Preliminary Injunction and Confirms Intention t..
09/08 QIAGEN : Welcomes U.S. Guidance for Latent TB Testing in Primary Car..
09/08 QIAGEN : welcomes U.S. guidance for latent TB testing in primary car..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales1 3061 3451 2811 3461 4301 526
Operating income (EBITDA)404394467405452483
Operating profit (EBIT)318313315310341380
Pre-Tax Profit (EBT)37,3-----
Net income69,1117127128182224
P/E ratio82,148,951,249,236,830,7
EPS ( $ )0,290,480,540,550,740,89
Dividend per Share ( $ )------
Yield------
Reference price ( $ )23.8123.4627.6527.327.327.3
Announcement Date01/29/2014
06:00am
01/29/2015
03:06pm
02/02/2016
11:46pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt465595639541293209
Finance------
Operating income (EBITDA)404394467405452483
Leverage
(Debt/EBITDA)
1,15x1,51x1,37x1,34x0,65x0,43x
Capital Expenditure84,586,697,8101102110
Book Value Per Share (BVPS)11,6 $11,4 $11,0 $11,5 $12,0 $12,7 $
Cash Flow per Share1,07 $1,19 $1,34 $1,53 $1,66 $1,82 $
Announcement Date01/29/2014
06:00am
01/29/2015
03:06pm
02/02/2016
11:46pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 6 544 M$ -
Entreprise Value (EV) 7 085 M$ 6 837 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 49,2x 36,8x
Capitalization / Revenue 4,86x 4,57x
EV / Revenue 5,27x 4,78x
EV / EBITDA 17,5x 15,1x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,37x 2,28x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 23,0% 23,8%
operating Leverage (Delta EBIT / Delta Sales) - 1,58x
Net Margin (Net Profit / Revenue) 9,53% 12,7%
ROA (Net Profit / Asset) 4,48% 5,25%
ROE (Net Profit / Equities) 8,51% 9,25%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   7,49% 7,12%
Cash Flow / Sales 26,7% 27,2%
Capital Intensity (Assets / Sales) 2,13x 2,43x
Financial Leverage (Net Debt / EBITDA) 1,34x 0,65x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend